Why Novavax and Endo International Stocks Are Rising Today
Novavax (NASDAQ: NVAX), a biotech company that is developing a vaccine for COVID-19, and Endo International (NASDAQ: ENDP), a pharmaceutical company, are both rising sharply on the stock market on Friday. As of 11:32 a.m. EDT today, shares of Novavax are up by 11.6%, while Endo International's stock is up by 5.8%. First, after the closing of yesterday's trading session, Novavax announced it was initiating a phase 3 clinical trial in partnership with the U.K. government for its coronavirus vaccine candidate, NVX-CoV2373.
